Developer docs
API playgroundTry for free, no card

Search company profiles

AposHealth

Full company profile

uuid0000zza

Namestring
AposHealth
Legal namestring
Apos US Management, Inc.
Websiteurl
aposhealth.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

AposHealth is a privately held, New York-based healthcare technology company founded in 2004 that has developed Apos®, an FDA-cleared and CE-marked foot-worn medical device for the non-invasive treatment of chronic musculoskeletal conditions, primarily knee osteoarthritis, with extensions into chronic hip pain, lower back pain, and ankle pain. The device uses proprietary configurable pods (Pertupods) on the sole that introduce controlled microinstabilities during walking, combined with AI-supported gait analysis, to redistribute forces across joints and retrain neuromuscular pathways during a patient's normal daily activity. Treatment is delivered as a personalized program: a certified clinician evaluates the patient, calibrates the device to their unique anatomy and biomechanics, and the patient wears the device approximately one hour per day at home, with periodic re-calibration and clinical follow-up. AposCare teletherapy services extend the model to remote patients through a wholly-owned clinical subsidiary (New York City Physical Therapy, PLLC d/b/a AposCare).

The company's underlying technology rests on three reinforcing layers: (1) a hardware IP base anchored by eight or more U.S. patents with international equivalents covering the Pertupod mechanism, the gait-retraining methodology, the precision mapping system, and adjacent indications; (2) an extensive clinical evidence base of 75+ peer-reviewed publications including a JAMA 2020 randomized study; and (3) an accumulated data asset of 150,000+ treated patients across three continents, which feeds AI-assisted device calibration and clinical decision support. Regulatory and guideline endorsements — FDA clearance, CE marking, NICE recommendation, NHS England MedTech Funding Mandate selection, and EULAR guideline inclusion for knee and hip OA — meaningfully de-risk clinical adoption.

AposHealth generates revenue through a hybrid model combining device-and-treatment-program sales, clinician/provider services, employer MSK benefit programs, health-plan coverage, and government contracts including a five-year VA Federal Supply Schedule contract through February 2027. The go-to-market is sales-led and multi-channel: direct engagement with healthcare providers who prescribe and fit the device, dedicated sales motion to employers and health plans via brokers and consultants, AposCare virtual visits for remote patients, and direct-to-consumer awareness marketing. Patient payment is enabled through FSA/HSA funds, financing plans, and insurance reimbursement where covered. The company employs 51–100 people and is led by Clifford Bleustein, MD, MBA as President and CEO.

Short descriptiontext

AposHealth develops Apos®, an FDA-cleared foot-worn medical device using AI-supported gait analysis and proprietary Pertupods to treat chronic musculoskeletal pain, including knee osteoarthritis. The company serves patients, clinicians, employers, and health plans across three continents.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
musculoskeletal treatment, medical device therapy, gait retraining system, joint pain management, teletherapy services
Industry2 codes
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLALADAC
Musculoskeletal (MSK) & Physical Therapy Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists621340
  • Home Health Care Services62161
SIC code4 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Home Health Care Services8082
Product category
Musculoskeletal Medical Device and Therapy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales and Treatment Program
TypeOne Time License
Description

AposHealth generates revenue through the sale of its Apos foot-worn medical device and associated treatment program. Patients pay using FSA, HSA, financing plans, or insurance. The treatment program includes gait analysis, personalized device calibration, and ongoing clinical follow-up.

aposhealth.com
2Healthcare Provider Services
TypeProfessional Services
Description

Revenue from physical therapists and clinicians who provide Apos treatment to patients, including evaluation, device fitting, and ongoing treatment supervision.

aposhealth.com
3Government and Institutional Contracts
TypeSubscription Recurring
Description

Revenue from federal supply schedule contracts such as the VA Federal Supply Schedule contract enabling purchase by federal agencies, tribal organizations, and qualified nonprofit customers.

aposhealth.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Insurance and FSA/HSA Coverage
ModelOtherBilling cadencePay-as-you-go
Notes

Treatment may be covered by health insurance. FSA and HSA funds can be used. Financing plans are available. No specific price points publicly disclosed.

aposhealth.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1AposCare
Description

Teletherapy and remote care services offered through New York City Physical Therapy, PLLC

aposhealth.com
Core offering1 text field

AposHealth sells the Apos® foot-worn medical device, an FDA-cleared and CE-marked system that uses AI-supported gait analysis and proprietary Pertupods to deliver personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain. The offering is complemented by clinician-led fitting, ongoing clinical supervision, and the AposCare teletherapy service that enables remote patient consultations and follow-up. The device is worn at home for approximately one hour daily as part of a structured treatment program paid for via insurance, FSA/HSA, or financing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 70% pain reduction (vs. 35% in controls) - JAMA 2020 study
+8 more records
Product overview1 text field

AposHealth offers the Apos® System, a comprehensive musculoskeletal care solution consisting of a foot-worn medical device (Apos®) with proprietary Pertupods, accompanied by AposCare teletherapy services. The system uses biomechanical redistribution and neuromuscular retraining to address knee osteoarthritis, chronic hip pain, and lower back pain. Patients receive personalized treatment plans including gait analysis, device calibration, and ongoing clinical support through virtual or in-person consultations.

Product and service5 records
1Apos® foot-worn medical device
CategoryMusculoskeletal medical device
Description

FDA-cleared, CE-marked foot-worn medical device that delivers personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain through gait retraining and weight redistribution. The device is fitted by certified clinicians and worn at home for approximately one hour per day as part of a structured treatment program.

2AposCare teletherapy service
CategoryTeletherapy and remote clinical services
Description

Teletherapy and remote care service delivered through New York City Physical Therapy, PLLC, providing virtual office visits, remote consultations, and follow-up care for patients undergoing Apos® treatment. Designed to extend AposHealth's clinical reach beyond in-person provider visits.

3Apos® treatment program
CategoryMusculoskeletal care program
Description

Clinician-led treatment program combining AI-supported gait analysis, personalized Apos® device calibration, in-person fitting, and ongoing clinical follow-up. Targets patients with knee osteoarthritis, chronic hip pain, lower back pain, and ankle pain and is delivered through certified Apos clinicians and the AposCare teletherapy platform.

4Employer MSK benefits program
CategoryEnterprise MSK benefit program
Description

Enterprise offering that provides AposHealth's MSK treatment program as an employee benefit through employer-sponsored health plans, with focus on reducing surgical interventions, pain medication use, and overall healthcare spend. Designed for HR/benefits leaders and benefits brokers.

5Federal Supply Schedule contract offering
CategoryGovernment federal supply contract
Description

Government offering that enables the U.S. Department of Veterans Affairs, tribal organizations, and qualified nonprofit customers to purchase the Apos® device under a five-year Federal Supply Schedule contract for veterans with knee osteoarthritis.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-04-23
Description

AposHealth partnered with Manifest Media's Game Recognizes Game podcast to launch a bold campaign aimed at revolutionizing musculoskeletal care. The partnership leads a national conversation on MSK recovery, greatness, and Apos treatment through talent and media collaboration.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital MSK platform offering AI-guided exercise therapy, PT coaching, and wearable sensors for back, knee, hip, and other joint pain. Targets the same employer and health-plan channels as AposHealth and represents its largest scaled digital competitor.

2Sword Health
TypeDirect peer
Description

Virtual MSK care platform combining digital exercise therapy with pelvic-floor and women's-health extensions. Competes head-to-head with Apos in employer benefits and value-based MSK contracts with a software-only model.

TypeDirect peer
Description

Digital MSK and chronic-pain app providing self-management exercise programs and AI motion tracking. Targets similar employer and payor channels and competes for non-invasive MSK treatment share.

TypeDirect peer
Description

Hybrid in-person and virtual MSK care practice combining physicians, PTs, and health coaches for back, joint, and muscle conditions. Competes with Apos in the value-based-care and employer-sponsored MSK space.

TypeDirect peer
Description

Virtual physical therapy platform for MSK recovery and prevention, distributed through health plans and employers. Provides digital PT programs that overlap with Apos's gait-retraining and joint-pain focus.

TypeBroad incumbent
Description

Public/established digital chronic-care company with MSK as one of several conditions (diabetes, hypertension, behavioral health). Competes for the same employer benefit dollars but offers a broader chronic-care platform.

TypeBroad incumbent
Description

Large orthopedic medical-device manufacturer producing joint implants and surgical equipment. Represents the surgical alternative Apos positions against for knee and hip OA, and a potential acquirer in the orthopedic-device category.

TypeBroad incumbent
Description

Global orthopedic medical-device leader in knee and hip replacements. Competes indirectly as the surgical treatment Apos aims to delay or avoid, and has been expanding into digital and conservative-care MSK solutions.

TypeEmerging player
Description

Manufacturer of premium OTC foot orthotics and insoles. Adjacent in the foot-worn biomechanical category, serving similar consumer foot/lower-extremity pain needs at a lower price point and OTC distribution.

TypeBroad incumbent
Description

Mass-market OTC foot-care and insole brand owned by Bayer. Competes for consumers seeking foot and lower-extremity pain relief at low price points, though without Apos's prescription-grade regulatory clearance and clinical evidence.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AposHealth

Musculoskeletal Medical Device and Therapy Servicesaposhealth.com

AposHealth develops Apos®, an FDA-cleared foot-worn medical device using AI-supported gait analysis and proprietary Pertupods to treat chronic musculoskeletal pain, including knee osteoarthritis. The company serves patients, clinicians, employers, and health plans across three continents.

What AposHealth does

AposHealth is a privately held, New York-based healthcare technology company founded in 2004 that has developed Apos®, an FDA-cleared and CE-marked foot-worn medical device for the non-invasive treatment of chronic musculoskeletal conditions, primarily knee osteoarthritis, with extensions into chronic hip pain, lower back pain, and ankle pain. The device uses proprietary configurable pods (Pertupods) on the sole that introduce controlled microinstabilities during walking, combined with AI-supported gait analysis, to redistribute forces across joints and retrain neuromuscular pathways during a patient's normal daily activity. Treatment is delivered as a personalized program: a certified clinician evaluates the patient, calibrates the device to their unique anatomy and biomechanics, and the patient wears the device approximately one hour per day at home, with periodic re-calibration and clinical follow-up. AposCare teletherapy services extend the model to remote patients through a wholly-owned clinical subsidiary (New York City Physical Therapy, PLLC d/b/a AposCare).

The company's underlying technology rests on three reinforcing layers: (1) a hardware IP base anchored by eight or more U.S. patents with international equivalents covering the Pertupod mechanism, the gait-retraining methodology, the precision mapping system, and adjacent indications; (2) an extensive clinical evidence base of 75+ peer-reviewed publications including a JAMA 2020 randomized study; and (3) an accumulated data asset of 150,000+ treated patients across three continents, which feeds AI-assisted device calibration and clinical decision support. Regulatory and guideline endorsements — FDA clearance, CE marking, NICE recommendation, NHS England MedTech Funding Mandate selection, and EULAR guideline inclusion for knee and hip OA — meaningfully de-risk clinical adoption.

AposHealth generates revenue through a hybrid model combining device-and-treatment-program sales, clinician/provider services, employer MSK benefit programs, health-plan coverage, and government contracts including a five-year VA Federal Supply Schedule contract through February 2027. The go-to-market is sales-led and multi-channel: direct engagement with healthcare providers who prescribe and fit the device, dedicated sales motion to employers and health plans via brokers and consultants, AposCare virtual visits for remote patients, and direct-to-consumer awareness marketing. Patient payment is enabled through FSA/HSA funds, financing plans, and insurance reimbursement where covered. The company employs 51–100 people and is led by Clifford Bleustein, MD, MBA as President and CEO.

AposHealth firmographics

Firmographics
Name
AposHealth
Legal name
Apos US Management, Inc.
Website
https://aposhealth.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
AposHealth develops Apos®, an FDA-cleared foot-worn medical device using AI-supported gait analysis and proprietary Pertupods to treat chronic musculoskeletal pain, including knee osteoarthritis. The company serves patients, clinicians, employers, and health plans across three continents.
Ownership category
akta.pro rank

AposHealth industry classification

Industry
Product category
Musculoskeletal Medical Device and Therapy Services
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340), Home Health Care Services (62161)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLALADAC
Musculoskeletal (MSK) & Physical Therapy Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms

Keywords

  • Musculoskeletal treatment
  • Medical device therapy
  • Gait retraining system
  • Joint pain management
  • Teletherapy services

Where AposHealth is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AposHealth business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Device Sales and Treatment Program: AposHealth generates revenue through the sale of its Apos foot-worn medical device and associated treatment program. Patients pay using FSA, HSA, financing plans, or insurance. The treatment program includes gait analysis, personalized device calibration, and ongoing clinical follow-up.
  2. Healthcare Provider Services: Revenue from physical therapists and clinicians who provide Apos treatment to patients, including evaluation, device fitting, and ongoing treatment supervision.
  3. Government and Institutional Contracts: Revenue from federal supply schedule contracts such as the VA Federal Supply Schedule contract enabling purchase by federal agencies, tribal organizations, and qualified nonprofit customers.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goInsurance and FSA/HSA Coverage

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

AposHealth product offering

Product offering

Core offering

AposHealth sells the Apos® foot-worn medical device, an FDA-cleared and CE-marked system that uses AI-supported gait analysis and proprietary Pertupods to deliver personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain. The offering is complemented by clinician-led fitting, ongoing clinical supervision, and the AposCare teletherapy service that enables remote patient consultations and follow-up. The device is worn at home for approximately one hour daily as part of a structured treatment program paid for via insurance, FSA/HSA, or financing.

Product overview

AposHealth offers the Apos® System, a comprehensive musculoskeletal care solution consisting of a foot-worn medical device (Apos®) with proprietary Pertupods, accompanied by AposCare teletherapy services. The system uses biomechanical redistribution and neuromuscular retraining to address knee osteoarthritis, chronic hip pain, and lower back pain. Patients receive personalized treatment plans including gait analysis, device calibration, and ongoing clinical support through virtual or in-person consultations.

Differentiator

Problem solved

Functional benefit

Brands

  • AposCare: Teletherapy and remote care services offered through New York City Physical Therapy, PLLC

Products and services

  • Apos® foot-worn medical device FDA-cleared, CE-marked foot-worn medical device that delivers personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain through gait retraining and weight redistribution. The device is fitted by certified clinicians and worn at home for approximately one hour per day as part of a structured treatment program.
  • AposCare teletherapy service Teletherapy and remote care service delivered through New York City Physical Therapy, PLLC, providing virtual office visits, remote consultations, and follow-up care for patients undergoing Apos® treatment. Designed to extend AposHealth's clinical reach beyond in-person provider visits.
  • Apos® treatment program Clinician-led treatment program combining AI-supported gait analysis, personalized Apos® device calibration, in-person fitting, and ongoing clinical follow-up. Targets patients with knee osteoarthritis, chronic hip pain, lower back pain, and ankle pain and is delivered through certified Apos clinicians and the AposCare teletherapy platform.
  • Employer MSK benefits program Enterprise offering that provides AposHealth's MSK treatment program as an employee benefit through employer-sponsored health plans, with focus on reducing surgical interventions, pain medication use, and overall healthcare spend. Designed for HR/benefits leaders and benefits brokers.
  • Federal Supply Schedule contract offering Government offering that enables the U.S. Department of Veterans Affairs, tribal organizations, and qualified nonprofit customers to purchase the Apos® device under a five-year Federal Supply Schedule contract for veterans with knee osteoarthritis.

Quantifiable outcome

  • 70% pain reduction (vs. 35% in controls) - JAMA 2020 study
  • +8 more outcomes

Companies that use AposHealth

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

AposHealth technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

AposHealth partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Manifest Media - Game Recognizes Game PodcastminorGTM or Marketing Partner · 23 April 2025AposHealth partnered with Manifest Media's Game Recognizes Game podcast to launch a bold campaign aimed at revolutionizing musculoskeletal care. The partnership leads a national conversation on MSK recovery, greatness, and Apos treatment through talent and media collaboration.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

AposHealth competitors and assessment

Company assessment

Direct peers

  • Hinge Health: Digital MSK platform offering AI-guided exercise therapy, PT coaching, and wearable sensors for back, knee, hip, and other joint pain. Targets the same employer and health-plan channels as AposHealth and represents its largest scaled digital competitor.
  • Sword Health: Virtual MSK care platform combining digital exercise therapy with pelvic-floor and women's-health extensions. Competes head-to-head with Apos in employer benefits and value-based MSK contracts with a software-only model.
  • Kaia Health: Digital MSK and chronic-pain app providing self-management exercise programs and AI motion tracking. Targets similar employer and payor channels and competes for non-invasive MSK treatment share.
  • Vori Health: Hybrid in-person and virtual MSK care practice combining physicians, PTs, and health coaches for back, joint, and muscle conditions. Competes with Apos in the value-based-care and employer-sponsored MSK space.
  • RecoveryOne: Virtual physical therapy platform for MSK recovery and prevention, distributed through health plans and employers. Provides digital PT programs that overlap with Apos's gait-retraining and joint-pain focus.

Broad incumbents

  • Omada Health: Public/established digital chronic-care company with MSK as one of several conditions (diabetes, hypertension, behavioral health). Competes for the same employer benefit dollars but offers a broader chronic-care platform.
  • Stryker: Large orthopedic medical-device manufacturer producing joint implants and surgical equipment. Represents the surgical alternative Apos positions against for knee and hip OA, and a potential acquirer in the orthopedic-device category.
  • Zimmer Biomet: Global orthopedic medical-device leader in knee and hip replacements. Competes indirectly as the surgical treatment Apos aims to delay or avoid, and has been expanding into digital and conservative-care MSK solutions.
  • Dr. Scholl's (Bayer): Mass-market OTC foot-care and insole brand owned by Bayer. Competes for consumers seeking foot and lower-extremity pain relief at low price points, though without Apos's prescription-grade regulatory clearance and clinical evidence.

Emerging players

  • Superfeet: Manufacturer of premium OTC foot orthotics and insoles. Adjacent in the foot-worn biomechanical category, serving similar consumer foot/lower-extremity pain needs at a lower price point and OTC distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

AposHealth social profiles

Digital presence

AposHealth compliance and trust

Trust signal

Compliance3 records

AposHealth financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AposHealth leadership team

Management profile

Number of profiles

Profiles15 records

AposHealth subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

AposHealth funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AposHealth M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AposHealth

What does AposHealth do?

AposHealth sells the Apos® foot-worn medical device, an FDA-cleared and CE-marked system that uses AI-supported gait analysis and proprietary Pertupods to deliver personalized biomechanical treatment for knee osteoarthritis, chronic hip pain, and lower back pain. The offering is complemented by clinician-led fitting, ongoing clinical supervision, and the AposCare teletherapy service that enables remote patient consultations and follow-up. The device is worn at home for approximately one hour daily as part of a structured treatment program paid for via insurance, FSA/HSA, or financing.

Is AposHealth a public or private company?

AposHealth is a private company. It is classified as venture growth investor backed and is currently operating.

When was AposHealth founded?

AposHealth was founded in 2004. It employs 51 to 100 people.

Where is AposHealth based?

AposHealth is headquartered in New York, United States, in the North America region.

How does AposHealth make money?

Three revenue lines are on record. Medical Device Sales and Treatment Program is the primary driver. The others are healthcare Provider Services and government and Institutional Contracts.

Who are AposHealth's main competitors?

Direct peers on record are Hinge Health, Sword Health, Kaia Health, Vori Health and RecoveryOne. Broad incumbents are Omada Health, Stryker, Zimmer Biomet and Dr. Scholl's (Bayer). Superfeet is listed as an emerging player.

Does AposHealth have an API?

No public API is recorded for AposHealth.

What industry is AposHealth in?

AposHealth's product category is Musculoskeletal Medical Device and Therapy Services. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLALADAC, Musculoskeletal (MSK) & Physical Therapy Virtual Care. Its NAICS code is 334510 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals